Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Isis surprised by disappointing results in Crohn's disease study of ISIS-2302

Dec. 22, 1999

Pivotal studies begin for Emitasol

Dec. 22, 1999

SK-951 demonstrates advantages over cisapride in models of impaired gastric emptying

Dec. 21, 1999

ViroPharma and Wyeth-Ayerst form alliance to develop HCV drugs

Dec. 16, 1999

Infliximab now available in U.K. through Centocor licensee

Dec. 16, 1999

InKine initiates phase II multicenter trial for IBD treatment

Dec. 15, 1999

Role for antioxidant in the treatment of ulcers: experimental results presented at Indian congress

Dec. 15, 1999

Nippon Chemiphar withdraws Leminon 80 application for approval in Japan

Dec. 15, 1999

Medivir investigates new treatments for hepatitis B

Dec. 13, 1999

Clinical development of ISIS-2302 progresses steadily

Dec. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...